Japan Precision Cancer Think Tank 2024

A key mission of the Precision Cancer Consortium’s (PCC) education and awareness workstream is to uncover the challenges faced by healthcare professionals (HCPs) when implementing Comprehensive Genomic Profiling (CGP).

Revolutionizing Cancer Trial Matching: PCC and Massive Bio’s AI-driven Multi-sponsor Study Delivers Promising Results

June 2024, ASCO Annual Meeting, Chicago – The Precision Cancer Consortium (PCC), in partnership with Massive Bio, has unveiled compelling results from a comprehensive study conducted on a multi-sponsor pharmaceutical platform. This study rigorously tested Massive Bio’s existing artificial intelligence (AI) system, designed to refine the clinical trial matching process using real-world clinical and genomic […]

Unique clinical trial matching initiative increases patient eligibility for trials

The problem: Clinical research teams manually match patients one-trial-at-a-time, taking approximately 25 minutes per trial. This limits patients’ choices and clinical trial enrolment rates. The solution: In 2023 a collaborative project between PCC and Massive Bio was initiated to find more eligible patients for biomarker-directed clinical trials by pre-screening all patients with NGS test results […]